Local Recurrence in Breast Cancer after Conservative Surgery: Timing of Radiotherapy and Sequencing of Chemotherapy

Anticancer Research

Volumn 24, Issue 2 C, 2004, Pages 1303-1306

  Donato, V ^a   Monaco, Alessia ^a,b   Messina, F ^a   De Sanctis, V ^a   Messineo, D ^a   Banelli, E ^a   Enrici, R Maurizi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Breast cancer; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHRONOSEQUENCE; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; REMISSION; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; FEMALE; FLUOROURACIL; HUMANS; MASTECTOMY, SEGMENTAL; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 2442635531     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fisher B, Anderson S, Bryant J et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347: 1233-1241, 2002.
2. Veronesi U, Cascinelli N, Mariani L et al: Twenty-year follow-up of randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347: 1227-1232, 2002.
3. Veronesi U, Salvadori B, Luini A, Banfi A, Zucali R, Del Vecchio M, Saccozzi R, Beretta E, Boracchi P, Faranre G, Galimberti V, Mezzanotte G, Sacchini V, Tana S and Marubibi E: Conservative treatment of early breast cancer. Long term results of 1232 cases treated with quadrantectomy axillary dissection and radiotherapy. Am Surg 211: 250-259, 1990.
4. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: An overview of the randomised trials. Lancet 352: 930-942, 1998.
5. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 351: 1451-1467, 1998.
6. Shah S, Doyle K, Lange EM, Shen P et al: Breast cancer recurrences in elderly patients after lumpectomy. Am Surg 68: 735-9, 2002.
7. Fredriksson I, Liljegren G, Amesson LG, Emdin SO et al: Local recurrence in the breast cancer after conservative surgerya study of prognosis and prognostic factors in 391 women. Eur J Cancer 38: 1860-70, 2002.
8. Fisher B, Dignam J, Wolmark N et al: Tamoxifene in treatment of intaductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial. Lancet 353: 1993-2000, 1999.
9. Fisher ER, Anderson S, Redmond C et al: Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP protocol B-06. Semin Surg Oncol 8: 161-166, 1992.
10. Fisher B, Dignam J, Wolmark N et al: Tamoxifene and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 89: 1673-1682, 1997.
11. Buchholz TA, Tucker S, Erwin J, Mathur D et al: Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol 19: 2240-2246, 2001.
12. Kurtz J. M, Spitalier J. M, Amalric R, Brandone H, Ayme Y, Jacquemier J, Hans D and Bressac C: The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys 18: 87-93, 1990.
13. Fowble BL, Schultz DJ, Overmoyer B et al: The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 30: 23-33, 1994.
14. Freedman G, Fowble B, Hanlon A et al: Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44: 1005-1015, 1999.
15. Schnitt SJ, Abner A, Gelman R et al: The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 74: 1746-1751, 1994.
16. Meric F, Mirza NQ, Vlastos G, Buchholz TA and Kuerer HM: Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 15;97(4): 926-33, 2003.
17. Park CC, Mitsumori M, Nixon A, Recht A et al: Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy and local recurrence. J Clin Oncol 18: 1668-75, 2000.
18. Bucholz TA, Austin-Seymour MM, Moe RE et al: Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 26: 23-35, 1993.
19. Froud PJ, Mates D, Jackson JS, Phillips N et al: Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys 46(2): 363-72, 2000.
20. Kurtz JM, Jacquemier J, Amalric R et al: Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 8: 591-598, 1990.
21. Haffty BG, Wilmarth L, Wilson L et al: Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patient. Cancer 73: 2543-2548, 1994:
22. Recht A, Coleman CN, Harris JR, Come SE and Gelman RS: Timing of radiotherapy in the treatment of early-stage breast cancer. J Clin Oncol 11: 192-193, 1993.
23. Recht A, Come S, Henderson I.C, Gelman R et al: The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 334: 1356-1361, 1996.
24. Buchholz TA, Hunt KK, Amosson CA et al: Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am 5: 159-164, 1999.
25. Recht A, Come SE, Gelman RS et al: Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage node-positive breast cancer: sequencing, timing and outcome. J Clin Oncol 9: 1662-1667, 1991.
26. Fowble BL, Fein DA, Hanlon AL et al: The impact of Tamoxifen on breast recurrence, cosmesis, complications, and' survival in estrogen receptor-positive early-stage breast cancer. Int J Radiat Oncol Biol Phys 35: 669-677, 1996.